Ledger.Open graph →
SEC Form D · filed August 7, 2025

Coeptis Therapeutics Holdings, Inc

Offering
$5.0M
Sold
$4.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WEXFORD, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Brian Cogley · Wexford, PAExecGene M. Salkind · Wexford, PADirectorDavid Mehalick · Wexford, PAExec · DirectorDaniel Yerace · Wexford, PADirectorPhilippe M. Deschamps · Wexford, PADirectorChristopher Cochran · Wexford, PADirectorChristopher Calise · New York, NYDirectorTara M. Desilva · Wexford, PADirectorChristopher Cochran · Wexford, PADirectorDavid Mehalick · Wexford, PAExec · DirectorChristopher Calise · New York, NYDirectorTara M. Desilva · Wexford, PADirectorDaniel Yerace · Wexford, PADirectorBrian Cogley · Wexford, PAExecGene M. Salkind · Wexford, PADirectorPhilippe M. Deschamps · Wexford, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗